Correction: Pharmacologic targeting of the PI3K/mTOR pathway controls release of angioregulators from primary human acute myeloid leukemia cells and their neighboring stromal cells

Eitemau Tebyg

• Pharmacological targeting of the PI3K/mTOR pathway alters the release of angioregulatory mediators both from primary human acute myeloid leukemia cells and their neighboring stromal cells
  gan: Reikvam, Håkon, et al.
  Cyhoeddwyd: (2013)
• Clonal Heterogeneity Reflected by PI3K-AKT-mTOR Signaling in Human Acute Myeloid Leukemia Cells and Its Association with Adverse Prognosis
  gan: Nepstad, Ina, et al.
  Cyhoeddwyd: (2018)
• Resistance to the Antiproliferative In Vitro Effect of PI3K-Akt-mTOR Inhibition in Primary Human Acute Myeloid Leukemia Cells Is Associated with Altered Cell Metabolism
  gan: Nepstad, Ina, et al.
  Cyhoeddwyd: (2018)
• The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells
  gan: Nepstad, Ina, et al.
  Cyhoeddwyd: (2020)
• Effects of insulin and pathway inhibitors on the PI3K-Akt-mTOR phosphorylation profile in acute myeloid leukemia cells
  gan: Nepstad, Ina, et al.
  Cyhoeddwyd: (2019)